Inefficient Vaginal Transmission of Tenofovir-Resistant HIV-1

Journal of Virology - United States
doi 10.1128/jvi.01777-12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Vaginal Microbicides and the Prevention of HIV Transmission

The Lancet Infectious Diseases
Infectious Diseases
2008English

Vaginal Formulations for Prevention of Sexual Transmission of HIV

2018English

Inefficient Entry of Vicriviroc-Resistant HIV-1 via the Inhibitor-Ccr5 Complex at Low Cell Surface CCR5 Densities

Virology
Virology
2009English

Diminished Transmission of Drug Resistant HIV-1 Variants With Reduced Replication Capacity in a Human Transmission Model

Retrovirology
VirologyInfectious Diseases
2014English

Pharmacokinetic and Safety Analyses of Tenofovir and Tenofovir-Emtricitabine Vaginal Tablets in Pigtailed Macaques

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy

New England Journal of Medicine
Medicine
2009English

Persistence of Nevirapine-Resistant HIV-1 in Women After Single-Dose Nevirapine Therapy for Prevention of Maternal-To-Fetal HIV-1 Transmission

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Vaginal Transmission of Cell-Associated HIV-1 in the Mouse Is Blocked by a Topical, Membrane-Modifying Agent

Journal of Clinical Investigation
Medicine
2002English

A Topical Microbicide Gel Formulation of CCR5 Antagonist Maraviroc Prevents HIV-1 Vaginal Transmission in Humanized RAG-hu Mice

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy